DiaMedica Therapeutics Inc. Common Stock

-$0.07 (-1.68%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.

About DMAC

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).

CEO
Rick John Pauls
Employees
11
Headquarters
Minneapolis, Minnesota
Founded
2000

DMAC Key Statistics

Market Cap
76.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
252.60K
High Today
$4.22
Low Today
$4.06
Open Price
$4.16
Volume
167.87K
52 Week High
$10.88
52 Week Low
$3.00

DMAC Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure